OR
Orgenesis Inc.
ORGS · OTC
$0.59 +0.00% (+$0.00)
1M +0.00%
Market Cap $5.78M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/S 10.91x
P/FCF N/A
P/B N/A
Growth
0 /100
Declining Rev. growth 58.93%
FCF growth N/A
Book val. growth N/A
Profitability
0 /100
Weak FCF margin 3,194.91%
Op. margin 10,120.00%
Gross margin 1,080.19%
Quality
1 /100
Poor ROA 380.44%
Asset turnover 0.04x
ROIC 3,180.09%
Debt
0 /100
High Int. coverage -28.74x
Current ratio 0.25x
Net debt/EBITDA N/A
Stability
1 /100
Unstable Profitable years 0
EPS volatility 162.20%
Beta 3.14x
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre ORGS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Vered Caplan
Employees
77
Headquarters
Germantown
Evenimente viitoare
11 NOV.
Earnings
Upcoming earnings report